And this is similar to how many clinicians use other widely-adopted technologies. Consider antibodies: You know, as a clinician I may not know exactly where that part of an antibody kind of binds to, but I'm comfortable after looking at some of this clinical validation of using Lucentis, for example, for an injection, right. This is kind of like any new breakthrough technology: needs validation and needs transparency, but I think, you know, the medical community in general responds very well to new technologies that have been validated.